For research teamsHelp me find a study
Back to all studies
CompletedNCT01655680

Safety and Efficacy of ABT-126 for schizophrenia

This study is completed in the United States, in the United Kingdom, and in Russia. It is testing Safety and Efficacy of ABT-126 for schizophrenia.

SchizophreniaDrugFrom 20 Years to 65 Years

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore recruiting studies on this topic

Then choose your country and confirm availability with each study site.

In plain English

Key information made simple

What is this study testing?

This study is testing whether the Safety and Efficacy of ABT-126 may be useful for adults experiencing schizophrenia.

What would participation involve?

Participants may receive the Safety and Efficacy of ABT-126, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in Russia, in the United Kingdom, and in the United States.

Who is it mainly for?

This study appears to be mainly for adults with schizophrenia.

What should you check before joining?

Ask about the dose, safety monitoring, and possible side effects, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.

Your next step

Check the study details

Check the official source, then confirm these points with the research team.

View official study record (opens in a new tab)

  • Recruitment and eligibility

    Is a site open, and who can take part?

  • Visits and time

    Where are visits, can any be remote, and how much time is needed?

  • Costs and support

    What costs, reimbursement or compensation apply?

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateMay 2012
Recruitment status
Completed
Enrollment listed in the registry
432
Sponsor
AbbVie (prior sponsor, Abbott)
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States, United Kingdom, Russia
Age range
From 20 Years to 65 Years
Official registry ID
NCT01655680
Official title
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Parallel-Group, Phase 2 Study of the Safety and Efficacy of ABT-126 in the Treatment of Cognitive Deficits in Schizophrenia (CDS) in Nonsmokers

Check recruitment and locations

Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.

View official study record (opens in a new tab)

The overall study status can differ from each site's status. Open a country to see its locations and their registry status.

Russia · 20 sites
  • Site Reference ID/Investigator# 94476
    Chita
    Site status: Not listed — confirm with the team
  • Site Reference ID/Investigator# 94528
    Kazan'
    Site status: Not listed — confirm with the team
  • Site Reference ID/Investigator# 79517
    Lipetsk
    Site status: Not listed — confirm with the team
  • Site Reference ID/Investigator# 81934
    Moscow
    Site status: Not listed — confirm with the team
  • Site Reference ID/Investigator# 81935
    Moscow
    Site status: Not listed — confirm with the team
  • Site Reference ID/Investigator# 79516
    Moscow
    Site status: Not listed — confirm with the team
  • Site Reference ID/Investigator# 83116
    Novosibirsk
    Site status: Not listed — confirm with the team
  • Site Reference ID/Investigator# 80673
    Saint Petersburg
    Site status: Not listed — confirm with the team
  • Site Reference ID/Investigator# 85093
    Saint Petersburg
    Site status: Not listed — confirm with the team
  • Site Reference ID/Investigator# 97135
    Saint Petersburg
    Site status: Not listed — confirm with the team
  • Site Reference ID/Investigator# 97137
    Saint Petersburg
    Site status: Not listed — confirm with the team
  • Site Reference ID/Investigator# 83115
    Saint Petersburg
    Site status: Not listed — confirm with the team
  • Site Reference ID/Investigator# 97136
    Saint Petersburg
    Site status: Not listed — confirm with the team
  • Site Reference ID/Investigator# 84733
    Saint Petersburg
    Site status: Not listed — confirm with the team
  • Site Reference ID/Investigator# 81933
    Saratov
    Site status: Not listed — confirm with the team
  • Site Reference ID/Investigator# 79514
    Saratov
    Site status: Not listed — confirm with the team
  • Site Reference ID/Investigator# 79520
    Stavropol
    Site status: Not listed — confirm with the team
  • Site Reference ID/Investigator# 83117
    Yaroslavl
    Site status: Not listed — confirm with the team
  • Site Reference ID/Investigator# 97138
    Yekaterinburg
    Site status: Not listed — confirm with the team
  • Site Reference ID/Investigator# 79515
    Yekaterinburg
    Site status: Not listed — confirm with the team
United Kingdom · 7 sites
  • Site Reference ID/Investigator# 81938
    Brentford
    Site status: Not listed — confirm with the team
  • Site Reference ID/Investigator# 81940
    Edinburgh
    Site status: Not listed — confirm with the team
  • Site Reference ID/Investigator# 81939
    London
    Site status: Not listed — confirm with the team
  • Site Reference ID/Investigator# 92813
    London
    Site status: Not listed — confirm with the team
  • Site Reference ID/Investigator# 81937
    Newcastle upon Tyne
    Site status: Not listed — confirm with the team
  • Site Reference ID/Investigator# 81943
    Oxford
    Site status: Not listed — confirm with the team
  • Site Reference ID/Investigator# 82238
    Preston
    Site status: Not listed — confirm with the team
United States · 34 sites
  • Site Reference ID/Investigator# 75139
    Anaheim, California
    Site status: Not listed — confirm with the team
  • Site Reference ID/Investigator# 74894
    Bellflower, California
    Site status: Not listed — confirm with the team
  • Site Reference ID/Investigator# 74434
    Chino, California
    Site status: Not listed — confirm with the team
  • Site Reference ID/Investigator# 76593
    Costa Mesa, California
    Site status: Not listed — confirm with the team
  • Site Reference ID/Investigator# 73213
    Escondido, California
    Site status: Not listed — confirm with the team
  • Site Reference ID/Investigator# 72698
    Garden Grove, California
    Site status: Not listed — confirm with the team
  • Site Reference ID/Investigator# 75057
    La Habra, California
    Site status: Not listed — confirm with the team
  • Site Reference ID/Investigator# 72693
    National City, California
    Site status: Not listed — confirm with the team
  • Site Reference ID/Investigator# 77655
    Norwalk, California
    Site status: Not listed — confirm with the team
  • Site Reference ID/Investigator# 74895
    Oakland, California
    Site status: Not listed — confirm with the team
  • Site Reference ID/Investigator# 73977
    Oceanside, California
    Site status: Not listed — confirm with the team
  • Site Reference ID/Investigator# 73214
    Orange, California
    Site status: Not listed — confirm with the team
  • Site Reference ID/Investigator# 74453
    Pico Rivera, California
    Site status: Not listed — confirm with the team
  • Site Reference ID/Investigator# 74898
    Riverside, California
    Site status: Not listed — confirm with the team
  • Site Reference ID/Investigator# 98016
    San Bernardino, California
    Site status: Not listed — confirm with the team
  • Site Reference ID/Investigator# 86973
    San Diego, California
    Site status: Not listed — confirm with the team
  • Site Reference ID/Investigator# 75140
    San Diego, California
    Site status: Not listed — confirm with the team
  • Site Reference ID/Investigator# 73974
    San Gabriel, California
    Site status: Not listed — confirm with the team
  • Site Reference ID/Investigator# 74433
    Santa Ana, California
    Site status: Not listed — confirm with the team
  • Site Reference ID/Investigator# 72695
    Torrance, California
    Site status: Not listed — confirm with the team
  • Site Reference ID/Investigator# 75136
    New Haven, Connecticut
    Site status: Not listed — confirm with the team
  • Site Reference ID/Investigator# 75653
    Atlanta, Georgia
    Site status: Not listed — confirm with the team
  • Site Reference ID/Investigator# 74893
    Marietta, Georgia
    Site status: Not listed — confirm with the team
  • Site Reference ID/Investigator# 72697
    Chicago, Illinois
    Site status: Not listed — confirm with the team
  • Site Reference ID/Investigator# 76533
    Hoffman Estates, Illinois
    Site status: Not listed — confirm with the team
  • Site Reference ID/Investigator# 75056
    Wichita, Kansas
    Site status: Not listed — confirm with the team
  • Site Reference ID/Investigator# 72694
    Cedarhurst, New York
    Site status: Not listed — confirm with the team
  • Site Reference ID/Investigator# 75137
    Rochester, New York
    Site status: Not listed — confirm with the team
  • Site Reference ID/Investigator# 75053
    Staten Island, New York
    Site status: Not listed — confirm with the team
  • Site Reference ID/Investigator# 75413
    Philadelphia, Pennsylvania
    Site status: Not listed — confirm with the team
  • Site Reference ID/Investigator# 74553
    Dallas, Texas
    Site status: Not listed — confirm with the team
  • Site Reference ID/Investigator# 72696
    DeSoto, Texas
    Site status: Not listed — confirm with the team
  • Site Reference ID/Investigator# 75055
    Houston, Texas
    Site status: Not listed — confirm with the team
  • Site Reference ID/Investigator# 74896
    Houston, Texas
    Site status: Not listed — confirm with the team

Ask HopeStage to help me review this study

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Loading the security check...
Study ID: NCT01655680. We help you review the study, but cannot decide medical eligibility.
In practice

For you

Participation may contribute to research. Personal benefit is not guaranteed.

Ask the research team to explain the activities, time commitment, and follow-up involved.

Study sites are listed. Confirm the relevant site and any travel before making plans.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring medication or study treatment for people with schizophrenia. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

Does this study involve a medication?

This appears to be a medication / drug study involving ABT-126, Placebo. Phase 2 studies usually explore whether the intervention may work, while continuing to monitor safety.

Who might this study be for?

This study may concern people with schizophrenia; age range: From 20 Years to 65 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.

What would I likely need to do?

You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

What side effects, interactions, or treatment changes should I check?

If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by AbbVie (prior sponsor, Abbott), which appears to be unknown or unclear. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me
Related studies

Explore related studies

Other studies that may be relevant based on condition, country, or study type.